A detailed history of Blue Water Life Science Advisors, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 571,047 shares of GH stock, worth $13.1 Million. This represents 16.04% of its overall portfolio holdings.

Number of Shares
571,047
Previous 571,047 -0.0%
Holding current value
$13.1 Million
Previous $11.8 Million 39.99%
% of portfolio
16.04%
Previous 11.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $2.27 Million - $3.1 Million
-105,000 Reduced 15.53%
571,047 $15.4 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $3.89 Million - $7.05 Million
185,602 Added 37.84%
676,047 $24.2 Million
Q1 2023

May 15, 2023

SELL
$22.92 - $33.76 $8.66 Million - $12.8 Million
-378,000 Reduced 43.53%
490,445 $11.5 Million
Q4 2022

Feb 14, 2023

SELL
$25.44 - $59.78 $2.8 Million - $6.58 Million
-110,000 Reduced 11.24%
868,445 $23.6 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $6.3 Million - $8.8 Million
144,300 Added 17.3%
978,445 $52.7 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $4.98 Million - $13.4 Million
172,700 Added 26.11%
834,145 $33.6 Million
Q1 2022

May 18, 2022

BUY
$48.25 - $100.49 $13.1 Million - $27.2 Million
270,500 Added 69.19%
661,445 $43.8 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $23.4 Million - $31.8 Million
264,121 Added 208.26%
390,945 $39.1 Million
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $10.2 Million - $13.7 Million
-103,771 Reduced 45.0%
126,824 $15.9 Million
Q2 2021

Aug 13, 2021

BUY
$109.77 - $165.68 $4.97 Million - $7.5 Million
45,265 Added 24.42%
230,595 $28.6 Million
Q1 2021

May 14, 2021

BUY
$127.04 - $179.1 $5.64 Million - $7.96 Million
44,430 Added 31.53%
185,330 $28.3 Million
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $14.1 Million - $19.2 Million
140,900 New
140,900 $18.2 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.35B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Blue Water Life Science Advisors, LP Portfolio

Follow Blue Water Life Science Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Water Life Science Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Blue Water Life Science Advisors, LP with notifications on news.